CD274 and non-small cell lung carcinoma: Some studies conclude that there is an increase in PD-L1 ≥ 1% positivity in NSCLC cases of BAF loss versus an intact BAF, meanwhile no difference can be seen in the BAF status for cases with PD-L1 > 50% positive cells [19,35].